Company

Nectero Medical, Inc.

Nectero Medical develops minimally invasive treatments for abdominal aortic aneurysms.

About

Founded in 2017 and based in Arizona, Nectero Medical is developing the Nectero EAST® System for small- to mid-sized infrarenal abdominal aortic aneurysms. In April 2024, it raised USD 96 million in Series D funding led by Norwest Venture Partners, Boston Scientific Corporation, BioStar Capital, Cadence Healthcare Ventures, and Aphelion Capital.

2Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in